Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.68 USD
-0.25 (-8.53%)
Updated Aug 2, 2024 03:49 PM ET
After-Market: $2.77 +0.09 (3.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RKDA 2.68 -0.25(-8.53%)
Will RKDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RKDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RKDA
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
RKDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Other News for RKDA
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call
Arcadia Biosciences (RKDA) Announces Leadership Transition
Optimizing Growth: Arcadia Biosciences’ Strategic Divestitures and Expanding Market Share
Arcadia Biosciences price target lowered by $4 at H.C. Wainwright, here's why
RKDA and YSG among Consumer Staples movers